#21 Angelinvesting.it - From idea to Series A - Weekly Newsletter
Viagra or v-AI-gra
3 Minutes to reflect
If it hadn't been for Ian Osterloh, the world would have experienced far fewer intimate encounters. Little known to most, Osterloh is the researcher responsible for bringing Viagra to the world.
For an extended period of time, Pfizer, the pharmaceutical giant, had been diligently striving to create a drug to combat high blood pressure. However, their research efforts were consistently met with formidable obstacles, pushing them to the brink of surrender.
Refusing to succumb to adversity, Ian Osterloh persisted in reviewing the data, meticulously scrutinizing them for months. And then, he stumbled upon a pattern: an association with increased blood flow to the genital area. Recognizing the drug's potential as a treatment for erectile dysfunction, Osterloh saw a groundbreaking opportunity.
Recently, I had the privilege of engaging with some of the leading venture capitalists in the biomedical field, and their resounding consensus reverberated like a thunderclap: laboratory research stands at the precipice of a monumental turning point, propelled by the awe-inspiring capabilities of artificial intelligence.
The analysis of vast quantities of data amassed during clinical drug trials is rapidly transitioning from human-driven efforts to the domain of machines.
Imagine a future where Large Language Models (LLMs), emulating the tenacity displayed by Dr. Osterloh, become the standard in uncovering elusive patterns concealed within the intricate streams of data. With their unwavering perseverance, these cutting-edge AI systems will unravel groundbreaking insights, catalyzing the development of life-saving treatments.
2 Resources to pro level
This week, 2 incredible articles have been written about the consequences of this AI spring. They are exceptional. Marc Andreessen confirms himself as one of the greatest thinkers of our generation. The quality of his analysis is worth its weight in gold.
A brilliant interview on the Financial Times with science fiction writer Ted Chiang. A precise analysis that gives AI the rightful place it deserves, spoiler: at the service of humanity.. (Link)
1 Reason to be happy
Erectile dysfunction drugs market keeps growing 🚀🤣
Have a great weekend,
Simone
—
Want to read more: click here
Want to invest with me: click here
Want to share a deck: click here